We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALGN icon
526
Align Technology
ALGN
$12B
$1.26M 0.02%
+5,680
New +$1.29M
EMN icon
527
Eastman Chemical
EMN
$7.8B
$1.26M 0.02%
13,604
+1,275
+10% +$116K
ACHN
528
DELISTED
Achillion Pharmaceuticals
ACHN
$1.25M 0.02%
435,000
-5,000
-1% -$18.2K
CDK
529
DELISTED
CDK Global, Inc.
CDK
$1.25M 0.02%
17,560
– –
GPC icon
530
Genuine Parts
GPC
$17.1B
$1.25M 0.02%
13,153
-1,216
-8% -$111K
NTLA icon
531
Intellia Therapeutics
NTLA
$1.5B
$1.25M 0.02%
+65,000
New +$1.5M
BF.B icon
532
Brown-Forman Class B
BF.B
$12B
$1.24M 0.02%
28,313
+4,682
+20% +$179K
BG icon
533
Bunge Global
BG
$23.6B
$1.24M 0.02%
18,540
+9,407
+103% +$639K
CTAS icon
534
Cintas
CTAS
$82.4B
$1.24M 0.02%
31,900
-7,508
-19% -$285K
VAR
535
DELISTED
Varian Medical Systems, Inc.
VAR
$1.24M 0.02%
11,186
+1,456
+15% +$157K
CBAY
536
DELISTED
Cymabay Therapeutics
CBAY
$1.24M 0.02%
+135,000
New +$1.15M
CHRS icon
537
Coherus Oncology
CHRS
$217M
$1.24M 0.02%
141,000
-52,000
-27% -$557K
HSY icon
538
Hershey
HSY
$35.4B
$1.24M 0.02%
10,935
+1,034
+10% +$114K
DBVT
539
DBV Technologies
DBVT
$807M
$1.23M 0.02%
+5,000
New +$1.45M
ETR icon
540
Entergy
ETR
$54.1B
$1.22M 0.02%
29,922
-1,388
-4% -$58.1K
TXMD icon
541
TherapeuticsMD
TXMD
$23.8M
$1.21M 0.02%
4,000
-6,600
-62% -$1.84M
LPL icon
542
LG Display
LPL
$3.17B
$1.2M 0.02%
87,000
+7,000
+9% +$94.2K
IMVP
543
Invesco India ETF
IMVP
$122M
$1.19M 0.02%
+45,000
New +$1.14M
CE icon
544
Celanese
CE
$5.09B
$1.18M 0.02%
11,048
-3,254
-23% -$346K
CHRW icon
545
C.H. Robinson
CHRW
$22B
$1.18M 0.02%
13,281
-681
-5% -$55.6K
ELGX
546
DELISTED
Endologix Inc
ELGX
$1.18M 0.02%
22,000
– –
IFF icon
547
International Flavors & Fragrances
IFF
$19.4B
$1.17M 0.02%
7,688
+515
+7% +$77.4K
NOC icon
548
Northrop Grumman
NOC
$77B
$1.17M 0.02%
3,812
-12,125
-76% -$3.64M
DINO icon
549
HF Sinclair
DINO
$15.9B
$1.17M 0.02%
22,752
-3,649
-14% -$154K
ALDR
550
DELISTED
Alder Biopharmaceuticals
ALDR
$1.16M 0.02%
101,000
-16,000
-14% -$179K
20 21
22
23 24

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.